Can protein, zinc, and hormones actually fix low libido in women?

What did @drtazmd actually say?

The transcript captured from this video is largely incoherent, likely due to a transcription error or audio corruption. The readable portion says something like "Last night, we're gonna now hold me No more stuff." That is not a medical claim. So we are working primarily from the caption, which is a real medical claim in its own right.

The caption states that low libido in women "does not have to be this way" and pitches a "huge toolbox" including protein, zinc supplementation, peptides, hormones, and medications. That is a specific enough claim to fact-check, even if the spoken content is unverifiable from the transcript provided.

Does the science back this up?

Partially, yes. Low libido in women, particularly around perimenopause, is a well-documented clinical issue with real treatment options. But the "toolbox" framing oversimplifies a condition that is notoriously difficult to treat.

Hypoactive sexual desire disorder (HSDD) affects an estimated 10% of premenopausal women and higher rates in perimenopausal and postmenopausal populations (Shifren et al., 2008, Obstetrics and Gynecology). The FDA has approved exactly two medications for HSDD in premenopausal women: flibanserin (Addyi) and bremelanotide (Vyleesi). Neither has strong efficacy data. Flibanserin's clinical trials showed roughly 0.5 additional satisfying sexual events per month over placebo (Katz et al., 2013, Journal of Sexual Medicine). That is a modest benefit at best.

Low-dose testosterone is used off-label in women and has the most consistent evidence for improving libido in postmenopausal women (Davis et al., 2019, Lancet Diabetes and Endocrinology), though it is not FDA-approved for this indication. Zinc's role is real but limited. Peptides like PT-141 (bremelanotide) are in that toolbox too, though the compounded versions circulating on wellness platforms are not equivalent to the approved injectable.

What did they get wrong (or right)?

The core message, that women do not have to accept low libido and that options exist, is defensible. That part is right, and it addresses a real clinical gap where women are often dismissed.

What is less defensible is the framing that bundles protein, zinc, peptides, hormones, and medications as if they sit on the same shelf with similar evidence quality. They do not. Protein optimization and zinc have weak direct libido data. Zinc deficiency can suppress testosterone, but supplementing above sufficiency does not reliably boost libido (Prasad et al., 1996, Nutrition). Lumping this with FDA-approved medications or off-label testosterone therapy flattens a real hierarchy of evidence.

The peptide mention is worth flagging. "Peptides" in a wellness context often refers to compounded versions of agents like PT-141 or growth hormone secretagogues. These carry regulatory and safety questions that a TikTok caption is not going to resolve. Calling them part of a "toolbox" without that context is a shortcut that could steer women toward unvetted products.

What should you actually know?

Female sexual dysfunction is real medicine, not a lifestyle issue, and the evidence base is thinner than the wellness industry implies. Here is what actually holds up.

Testosterone therapy has the strongest evidence for libido in postmenopausal women, but it requires monitoring for androgenic side effects and is prescribed off-label in the US. Hormonal contraceptives can suppress libido in some women, and addressing that directly may matter more than adding supplements (Bancroft et al., 2003, Archives of Sexual Behavior). Psychosocial and relationship factors are significant contributors that no supplement addresses. A proper workup, thyroid function, prolactin levels, medication review, and depression screening, belongs before any "toolbox" discussion.

If a telehealth platform is offering this toolbox, ask specifically which interventions have FDA approval or peer-reviewed efficacy data for your specific situation. "Hormone balance" as a category is not a diagnosis.